NHS

CMHC Announces Housing Research Award Winners

Retrieved on: 
Thursday, February 29, 2024
Law school, Woman, Research, Violence, Architecture, CMHC, Assistant, University of Toronto, Housing, Government, Conference, NHS, Health, University, City, University of British Columbia, National Housing Conference, Associate, Humanities, Social

The Housing Research Awards recognize Canadian housing research, research training, knowledge mobilization and outreach activities that are impactful and innovative and help to build and sustain Canada's culture of research-based housing knowledge across key fields, including the social sciences and humanities, health, and technology.

Key Points: 
  • The Housing Research Awards recognize Canadian housing research, research training, knowledge mobilization and outreach activities that are impactful and innovative and help to build and sustain Canada's culture of research-based housing knowledge across key fields, including the social sciences and humanities, health, and technology.
  • Thank you to all of those who submitted their work for the 2023 Housing Research Awards, and congratulations to our winners.
  • This is the highest Housing Research Awards honour, recognizing a significant research contribution that helps us achieve our aspiration to make housing affordable for everyone in Canada.
  • CMHC contributes to the stability of the housing market and financial system, provides support for Canadians in housing need, and offers objective housing research and information to all levels of governments, consumers and the housing industry.

Bionical Solutions Appoints Chief Technology Officer to Create Innovative Data Products and Software for the Digital Business

Retrieved on: 
Thursday, February 29, 2024
Digital, NHS, Machine learning, Local government, Head

WILLINGTON, England, Feb. 29, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announced the appointment of Andrew Seward as Chief Technology Officer for the Digital business.

Key Points: 
  • WILLINGTON, England, Feb. 29, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announced the appointment of Andrew Seward as Chief Technology Officer for the Digital business.
  • He has been Chief Technology Officer at prominent HR software company, Mitrefinch Ltd, and has led product strategy and development at UK fintech company, Quint Group, and tech start-up, Cronofy.
  • Newly appointed Chief Technology Officer, Andrew Seward, said: "It is great to be joining Bionical at such an exciting time for the business.
  • I am looking forward to working closely with Gareth and the team to create innovative solutions."

Bionical Solutions Appoints Chief Technology Officer to Create Innovative Data Products and Software for the Digital Business

Retrieved on: 
Thursday, February 29, 2024
Digital, NHS, Machine learning, Local government, Head

WILLINGTON, England, Feb. 29, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announced the appointment of Andrew Seward as Chief Technology Officer for the Digital business.

Key Points: 
  • WILLINGTON, England, Feb. 29, 2024 /PRNewswire/ -- Bionical Solutions, a leading provider of technology enabled engagement and healthcare services to global pharmaceutical, biotech, healthcare companies and the NHS, today announced the appointment of Andrew Seward as Chief Technology Officer for the Digital business.
  • He has been Chief Technology Officer at prominent HR software company, Mitrefinch Ltd, and has led product strategy and development at UK fintech company, Quint Group, and tech start-up, Cronofy.
  • Newly appointed Chief Technology Officer, Andrew Seward, said: "It is great to be joining Bionical at such an exciting time for the business.
  • I am looking forward to working closely with Gareth and the team to create innovative solutions."

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

Retrieved on: 
Wednesday, February 28, 2024
Therapy, Workload, Breast cancer, Area, Odense University Hospital, Algorithm, Woman, Radiology, Pneumothorax, Artificial intelligence, AI, Research, Triage, Pathology, Deep learning, Use, AUC, Workflow, King's College London, NHS, ACV, ECR, Mammography, Radboud University Medical Center, Report, Patient, Poster, Human, Medical device

SEOUL, South Korea, Feb. 28, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the presentation of seven studies at the European Congress of Radiology (ECR) 2024, to be held in Vienna, Austria, from February 28 to March 3. Four will be presented through oral presentations and three as E-posters.

Key Points: 
  • Four out of seven AI products, including Lunit INSIGHT CXR, showed superior performance compared to human readers.
  • Lunit invites booth visitors at ECR 2024 to explore detailed information on the project and discuss potential future collaborations.
  • "We are proud to present our latest research findings at this year's ECR, demonstrating the robust performance and versatility of our Lunit INSIGHT suite in various clinical settings and scenarios.
  • Join Lunit at booth AI-15 in the EXPO X1 hall to witness how the Lunit INSIGHT suite is shaping the future of radiology across the globe.

TYMPAHEALTH CELEBRATES WORLD HEARING DAY WITH A CALL TO ACTION FOR EAR AND HEARING HEALTH: DON'T WAIT, HEAR CLEAR

Retrieved on: 
Tuesday, February 27, 2024
Social media, Hearing, Infection, Walgreen, Quality of life, Life, World Hearing Day, Ear, NHS, Hearing loss, Audiology, ENT, World Health Organization, Knowledge, Social stigma, Research, Personal protective equipment

But many factors can also affect ear and hearing health amongst younger demographics, including infections, wax build up, unsafe listening practices, amongst many others.

Key Points: 
  • But many factors can also affect ear and hearing health amongst younger demographics, including infections, wax build up, unsafe listening practices, amongst many others.
  • World Hearing Day (Sunday 3rd March), designated by the World Health Organization, serves as an annual reminder of the importance of hearing health and the need for early identification and intervention for hearing loss.
  • To celebrate World Hearing Day TympaHealth will be promoting their Don't Wait, Hear Clear message across social media and encouraging their ear and hearing health practitioner network to do the same.
  • TympaHealth has established partnerships with providers including Walgreen, Boots Alliance, Sonova Day Lewis Pharmacy, Demant (Hidden Hearing), Bupa and the NHS.

Oxehealth welcomes Todd Haedrich as Chief Executive Officer

Retrieved on: 
Tuesday, February 27, 2024
NHS, Research, Hospital, Machine learning, Growth, National Health Service, Patient, Software, Partnership

OXFORD, England, Feb. 27, 2024 /PRNewswire/ -- Oxehealth, a global leader in intelligent patient monitoring for behavioural health has announced the appointment of Todd Haedrich as Chief Executive Officer.

Key Points: 
  • OXFORD, England, Feb. 27, 2024 /PRNewswire/ -- Oxehealth, a global leader in intelligent patient monitoring for behavioural health has announced the appointment of Todd Haedrich as Chief Executive Officer.
  • Todd joins Oxehealth having had an extensive career in software and healthcare technology, building, leading, and growing successful companies in the US, Europe, and Asia-Pacific.
  • Todd Haedrich will be replacing outgoing CEO Hugh Lloyd-Jukes who commented, "It's been a huge privilege to lead Oxehealth.
  • Todd has the experience and qualities to lead Oxehealth and enable it to reach its full potential, ensuring that our global ambitions are realized over the coming years."

Oxehealth welcomes Todd Haedrich as Chief Executive Officer

Retrieved on: 
Tuesday, February 27, 2024
NHS, Research, Hospital, Machine learning, Growth, National Health Service, Patient, Software, Partnership

OXFORD, England, Feb. 27, 2024 /PRNewswire/ -- Oxehealth, a global leader in intelligent patient monitoring for behavioural health has announced the appointment of Todd Haedrich as Chief Executive Officer.

Key Points: 
  • OXFORD, England, Feb. 27, 2024 /PRNewswire/ -- Oxehealth, a global leader in intelligent patient monitoring for behavioural health has announced the appointment of Todd Haedrich as Chief Executive Officer.
  • Todd joins Oxehealth having had an extensive career in software and healthcare technology, building, leading, and growing successful companies in the US, Europe, and Asia-Pacific.
  • Todd Haedrich will be replacing outgoing CEO Hugh Lloyd-Jukes who commented, "It's been a huge privilege to lead Oxehealth.
  • Todd has the experience and qualities to lead Oxehealth and enable it to reach its full potential, ensuring that our global ambitions are realized over the coming years."

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

Retrieved on: 
Tuesday, February 27, 2024
Cancer Moonshot, AstraZeneca, Intel, Atrium Health, National Health Service, Quality of life, Hope, White, Risk, Social work, NHS, Health care, UC, Business, Patient, Accelerator, Dell Technologies, NHS England, Disease, Heart, Healthcare UK, Mortality, AWS, Cancer, Pharmaceutical industry

CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.

Key Points: 
  • CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.
  • The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations.
  • C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease.
  • Launched by the White House, this initiative marks a significant step toward realizing the Cancer Moonshot's vision of a 50% reduction in cancer mortality.

British Technology company, C the Signs, selected by the White House-Backed Accelerator Programme, CancerX, to half Cancer Deaths

Retrieved on: 
Tuesday, February 27, 2024
Cancer Moonshot, AstraZeneca, Intel, Atrium Health, National Health Service, Quality of life, Hope, White, Risk, Social work, NHS, Health care, UC, Business, Patient, Accelerator, Dell Technologies, NHS England, Disease, Heart, Healthcare UK, Mortality, AWS, Cancer, Pharmaceutical industry

CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.

Key Points: 
  • CancerX was unveiled by the White House in a landmark announcement last year to spearhead innovation in oncology.
  • The CancerX Accelerator programme aims to promote and fortify digital innovations in oncology by providing promising startups an opportunity to collaborate with leading cancer organizations.
  • C the Signs is an AI cancer prediction platform that identifies patients at risk of cancer at the earliest and most curable stage of the disease.
  • Launched by the White House, this initiative marks a significant step toward realizing the Cancer Moonshot's vision of a 50% reduction in cancer mortality.

Sorenson Awarded Supplier of Non-Spoken Language Interpreting for NHS North of England Commercial Procurement Collaborative

Retrieved on: 
Wednesday, February 21, 2024
Language, Public sector, Communication, Organic, NHS, School, CPC, NOE, Environment

LONDON, Feb. 21, 2024 /PRNewswire/ -- Sorenson, the leading provider of inclusive communication services for Deaf, Deafblind, and hard-of-hearing communities around the world, today announced Sign Language Interactions, SignVideo, and Sorenson Interpreting have been named as suppliers for the Language Services Framework "Non-Spoken Language Interpreting" for NHS North of England Commercial Procurement Collaborative (NOE CPC).

Key Points: 
  • LONDON, Feb. 21, 2024 /PRNewswire/ -- Sorenson, the leading provider of inclusive communication services for Deaf, Deafblind, and hard-of-hearing communities around the world, today announced Sign Language Interactions, SignVideo, and Sorenson Interpreting have been named as suppliers for the Language Services Framework "Non-Spoken Language Interpreting" for NHS North of England Commercial Procurement Collaborative (NOE CPC).
  • "We're incredibly proud of being chosen by the NHS to provide quality language services to local authority councils, schools, police forces, fire and rescue services, and charities across the U.K.," said Jorge Rodriguez, CEO of Sorenson.
  • "This appointment represents a significant achievement for Sign Language Interactions, SignVideo, and Sorenson Interpreting, and exemplifies NHS's commitment to effectively addressing language barriers and fostering an inclusive environment."
  • Membership in the NOE CPC is not a prerequisite for utilizing the services offered.